Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.004 per share ("Shares")
-
Shares outstanding
-
22,866,677
-
Total 13F shares
-
24,236,173
-
Share change
-
+702,435
-
Total reported value
-
$618,449,426
-
Put/Call ratio
-
2033%
-
Price per share
-
$25.52
-
Number of holders
-
84
-
Value change
-
+$18,484,148
-
Number of buys
-
38
-
Number of sells
-
38
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q2 2023
As of 30 Jun 2023 BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) had 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,236,173 shares of stock of the company.
Largest 10 holders included Deep Track Capital, LP, Paradigm Biocapital Advisors LP, Jefferies Financial Group Inc., First Light Asset Management, LLC, MORGAN STANLEY, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, JANUS HENDERSON GROUP PLC, Candriam S.C.A., Sio Capital Management, LLC, and ARMISTICE CAPITAL, LLC.
This table shows 84 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.